BLU-285 for advanced systemic mastocytosis
10 Dec 2017
BLU-285 for advanced systemic mastocytosis
The reality of pancreatic cancer
Personalised medicine for inherited breast cancer
A biological perspective for personalising immunotherapies
Personalised haematology treatments
The importance of increasing biomarker understanding
Prostate cancer in sub-Saharan Africa
Bevacizumab and colorectal cancer in geriatrics
Concluding the debate around dexrazoxane
Toxicities in treatments of lung cancers with respect to the elderly
Benefits and drawbacks of dexrazoxane
Encouraging age related reviews of three new breast cancer treatments